|
|||||
|
|
Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial |
|
| Authors: | Berger Jeffrey S Bhatt Deepak L Steg P Gabriel Steinhubl Steven R Montalescot Gilles Shao Mingyuan Hacke Werner Fox Keith A Berger Peter B Topol Eric J Lincoff A Michael |
| Institution: | New York University School of Medicine, New York, NY, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |